ACAD
33.68
-1.55
-4.40%
AEMD
4.89
-0.15
-2.98%
APRI
0.343
-0.002
-0.4638%
ARNA
1.77
-0.04
-2.21%
ATEC
8.98
+0.55
+6.52%
CNAT
2.06
-0.01
-0.48%
CRXM
0.2
+0.03
+14.63%
CYTX
2.02
-0.01
-0.49%
DXCM
89.74
-3.98
-4.25%
GNMK
11.69
-0.26
-2.18%
HALO
12.41
-0.1
-0.80%
ILMN
180.98
+0.63
+0.35%
INNV
0.26
-0.03
-9.11%
INO
9.54
-0.05
-0.52%
ISCO
1.85
+0.05
+2.78%
ISIS
57.56
0.00
0.00%
LGND
102.44
+2.8
+2.81%
LPTN
3.48
-0.09
-2.52%
MBVX
4.08
-0.15
-3.55%
MEIP
1.74
+0.01
+0.58%
MNOV
7.61
+0.05
+0.66%
MRTX
6.72
-0.06
-0.88%
MSTX
0.106
-0.007
-6.5084%
NBIX
51.42
-1.94
-3.64%
NUVA
67.31
+0.18
+0.27%
ONCS
1.71
-0.02
-1.16%
ONVO
3.86
-0.03
-0.77%
OREX
3.29
+0.05
+1.54%
OTIC
17.07
-0.27
-1.56%
QDEL
21.91
-0.2
-0.90%
RCPT
231.96
0.00
0.00%
RGLS
3.45
-0.06
-1.71%
RMD
64.74
+0.24
+0.37%
SPHS
3.08
-0.22
-6.67%
SRNE
7.86
+0.2
+2.61%
TROV
4.49
+0.01
+0.22%
VICL
3.12
+0.01
+0.32%
VOLC
18
0.00
0.00%
ZGNX
11.21
+0.67
+6.36%
ACAD
33.68
-1.55
-4.40%
AEMD
4.89
-0.15
-2.98%
APRI
0.343
-0.002
-0.4638%
ARNA
1.77
-0.04
-2.21%
ATEC
8.98
+0.55
+6.52%
CNAT
2.06
-0.01
-0.48%
CRXM
0.2
+0.03
+14.63%
CYTX
2.02
-0.01
-0.49%
DXCM
89.74
-3.98
-4.25%
GNMK
11.69
-0.26
-2.18%
HALO
12.41
-0.1
-0.80%
ILMN
180.98
+0.63
+0.35%
INNV
0.26
-0.03
-9.11%
INO
9.54
-0.05
-0.52%
ISCO
1.85
+0.05
+2.78%
ISIS
57.56
0.00
0.00%
LGND
102.44
+2.8
+2.81%
LPTN
3.48
-0.09
-2.52%
MBVX
4.08
-0.15
-3.55%
MEIP
1.74
+0.01
+0.58%
MNOV
7.61
+0.05
+0.66%
MRTX
6.72
-0.06
-0.88%
MSTX
0.106
-0.007
-6.5084%
NBIX
51.42
-1.94
-3.64%
NUVA
67.31
+0.18
+0.27%
ONCS
1.71
-0.02
-1.16%
ONVO
3.86
-0.03
-0.77%
OREX
3.29
+0.05
+1.54%
OTIC
17.07
-0.27
-1.56%
QDEL
21.91
-0.2
-0.90%
RCPT
231.96
0.00
0.00%
RGLS
3.45
-0.06
-1.71%
RMD
64.74
+0.24
+0.37%
SPHS
3.08
-0.22
-6.67%
SRNE
7.86
+0.2
+2.61%
TROV
4.49
+0.01
+0.22%
VICL
3.12
+0.01
+0.32%
VOLC
18
0.00
0.00%
ZGNX
11.21
+0.67
+6.36%
Home » Archive by Category

Xconomy

Making the Price Right: Ideas To Change Drug Costs Gain Momentum

April 5, 2016 – 5:45 am

If the U.S. presidential primaries continue their current trajectories, the two contenders come autumn will have at least one thing in common: a stated desire to do something about high drug prices….

[[Click headline to continue reading.]]

Making the Price Right: Ideas To Change Drug Costs Gain Momentum

April 5, 2016 – 5:45 am

If the U.S. presidential primaries continue their current trajectories, the two contenders come autumn will have at least one thing in common: a stated desire to do something about high drug prices….

[[Click headline to continue reading.]]

$220M Richer, Human Longevity Ups Ante In Genomics Business Race

April 4, 2016 – 4:56 pm

Human Longevity, the private San Diego startup aiming to turn DNA from tens of thousands of people into a range of new businesses, said this afternoon it has reeled in $220 million in venture cash….

[[Click headline to continue reading.]]

Napa Summit 2016: Request Your Invite to Our Most Special Event

April 4, 2016 – 6:46 am

There are all sorts of reasons for requesting an invitation to Xconomy’s Napa Summit, which will take place in just six weeks—on May 16-17.  One is the fantastic array of speakers: John Maeda,…

[[Click headline to continue reading.]]

When Data Meets Genomics, Where Does Computing Power Come From?

April 1, 2016 – 8:09 am

San Antonio—Even as genome sequencing has risen in prevalence and declined in cost during the last decade, it still has many scientists perplexed from a data standpoint. As it becomes more…

[[Click headline to continue reading.]]

What’s Ahead for Biotech in 2016: Q&A With BIO Chair Ron Cohen

March 31, 2016 – 6:55 am

Biotechnology is a tricky business. We all know the trials and tribulations—and costs—of bringing novel drugs to market. In the past six months or so, a new round of drug pricing upheaval…

[[Click headline to continue reading.]]

New PureTech Startup Commense Aims to Protect Babies From Disease

March 31, 2016 – 5:50 am

[Updated, 12:15 pm ET, see below] Boston company creator PureTech Health already has one microbiome startup in its portfolio, Vedanta Biosciences. Today it’s unveiled a second one, Commense, with a…

[[Click headline to continue reading.]]

The Xconversation: Vaccine Developer Meets Energy Innovator, Part II

March 30, 2016 – 3:20 am

There’s no such thing as failure, as long as you view it in the proper light. That’s the philosophy of scientist-entrepreneurs Darrick Carter, vice president of adjuvant technology at…

[[Click headline to continue reading.]]

The Xconversation: Vaccine Developer Meets Energy Innovator, Part I

March 29, 2016 – 3:20 am

What do vaccines have to do with batteries? Let your mind’s eye travel to the cellular membrane, where a ligand is enveloped by a receptor, spurring a subtle change in the cell. (Bear with me.)…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Gilead, Affymetrix, Acutus, Frazier & More

March 25, 2016 – 7:13 am

Gilead Sciences is back at the top of our chart for the second week in a row. After halting trials last week in the United States and Europe over its cancer drug idelalisib, a federal jury in San…

[[Click headline to continue reading.]]